Global Botulinum Neurotoxins Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Botulinum Neurotoxins Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Botulinum Neurotoxins Market Size Growth Rate by Product
  • 1.4.2 Botulinum Neurotoxins A (BoNT/A)
  • 1.4.3 Botulinum Neurotoxins B (BoNT/B)
  • 1.4.4 Botulinum Neurotoxins E (BoNT/E)
  • 1.4.5 Botulinum Neurotoxins F (BoNT/F)
  • 1.4.6 Botulinum Neurotoxins C (BoNT/C)
  • 1.4.7 Botulinum Neurotoxins D (BoNT/D)
  • 1.4.8 Botulinum Neurotoxins G (BoNT/G)
• 1.5 Market by End User
  • 1.5.1 Global Botulinum Neurotoxins Market Size Growth Rate by End User
  • 1.5.2 Medical Uses
  • 1.5.3 Cosmetics
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Botulinum Neurotoxins Market Size
  • 2.1.1 Global Botulinum Neurotoxins Revenue 2014-2025
  • 2.1.2 Global Botulinum Neurotoxins Sales 2014-2025
• 2.2 Botulinum Neurotoxins Growth Rate by Regions
  • 2.2.1 Global Botulinum Neurotoxins Sales by Regions
  • 2.2.2 Global Botulinum Neurotoxins Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Botulinum Neurotoxins Sales by Manufacturers
  • 3.1.1 Botulinum Neurotoxins Sales by Manufacturers
  • 3.1.2 Botulinum Neurotoxins Sales Market Share by Manufacturers
  • 3.1.3 Global Botulinum Neurotoxins Market Concentration Ratio (CR5 and HHI)
• 3.2 Botulinum Neurotoxins Revenue by Manufacturers
  • 3.2.1 Botulinum Neurotoxins Revenue by Manufacturers (2014-2019)
  • 3.2.2 Botulinum Neurotoxins Revenue Share by Manufacturers (2014-2019)
• 3.3 Botulinum Neurotoxins Price by Manufacturers
• 3.4 Botulinum Neurotoxins Manufacturing Base Distribution, Product Types
  • 3.4.1 Botulinum Neurotoxins Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Botulinum Neurotoxins Product Type
  • 3.4.3 Date of International Manufacturers Enter into Botulinum Neurotoxins Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Botulinum Neurotoxins Sales by Product
• 4.2 Global Botulinum Neurotoxins Revenue by Product
• 4.3 Botulinum Neurotoxins Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Botulinum Neurotoxins Breakdown Data by End User

6 North America

• 6.1 North America Botulinum Neurotoxins by Countries
  • 6.1.1 North America Botulinum Neurotoxins Sales by Countries
  • 6.1.2 North America Botulinum Neurotoxins Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Botulinum Neurotoxins by Product
• 6.3 North America Botulinum Neurotoxins by End User

7 Europe

• 7.1 Europe Botulinum Neurotoxins by Countries
  • 7.1.1 Europe Botulinum Neurotoxins Sales by Countries
  • 7.1.2 Europe Botulinum Neurotoxins Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Botulinum Neurotoxins by Product
• 7.3 Europe Botulinum Neurotoxins by End User

8 Asia Pacific

• 8.1 Asia Pacific Botulinum Neurotoxins by Countries
  • 8.1.1 Asia Pacific Botulinum Neurotoxins Sales by Countries
  • 8.1.2 Asia Pacific Botulinum Neurotoxins Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Botulinum Neurotoxins by Product
• 8.3 Asia Pacific Botulinum Neurotoxins by End User

9 Central & South America

• 9.1 Central & South America Botulinum Neurotoxins by Countries
  • 9.1.1 Central & South America Botulinum Neurotoxins Sales by Countries
  • 9.1.2 Central & South America Botulinum Neurotoxins Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Botulinum Neurotoxins by Product
• 9.3 Central & South America Botulinum Neurotoxins by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Botulinum Neurotoxins by Countries
  • 10.1.1 Middle East and Africa Botulinum Neurotoxins Sales by Countries
  • 10.1.2 Middle East and Africa Botulinum Neurotoxins Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Botulinum Neurotoxins by Product
• 10.3 Middle East and Africa Botulinum Neurotoxins by End User

11 Company Profiles

• 11.1 Johnson & Johnson
  • 11.1.1 Johnson & Johnson Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Johnson & Johnson Botulinum Neurotoxins Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Johnson & Johnson Botulinum Neurotoxins Products Offered
  • 11.1.5 Johnson & Johnson Recent Development
• 11.2 GSK
  • 11.2.1 GSK Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 GSK Botulinum Neurotoxins Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 GSK Botulinum Neurotoxins Products Offered
  • 11.2.5 GSK Recent Development
• 11.3 Allergan
  • 11.3.1 Allergan Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Allergan Botulinum Neurotoxins Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Allergan Botulinum Neurotoxins Products Offered
  • 11.3.5 Allergan Recent Development
• 11.4 Chong Kun Dang
  • 11.4.1 Chong Kun Dang Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Chong Kun Dang Botulinum Neurotoxins Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Chong Kun Dang Botulinum Neurotoxins Products Offered
  • 11.4.5 Chong Kun Dang Recent Development
• 11.5 Eisai
  • 11.5.1 Eisai Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Eisai Botulinum Neurotoxins Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Eisai Botulinum Neurotoxins Products Offered
  • 11.5.5 Eisai Recent Development
• 11.6 Nestle
  • 11.6.1 Nestle Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Nestle Botulinum Neurotoxins Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Nestle Botulinum Neurotoxins Products Offered
  • 11.6.5 Nestle Recent Development
• 11.7 Galderma
  • 11.7.1 Galderma Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Galderma Botulinum Neurotoxins Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Galderma Botulinum Neurotoxins Products Offered
  • 11.7.5 Galderma Recent Development
• 11.8 Ipsen
  • 11.8.1 Ipsen Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Ipsen Botulinum Neurotoxins Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Ipsen Botulinum Neurotoxins Products Offered
  • 11.8.5 Ipsen Recent Development
• 11.9 Hugel
  • 11.9.1 Hugel Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Hugel Botulinum Neurotoxins Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Hugel Botulinum Neurotoxins Products Offered
  • 11.9.5 Hugel Recent Development
• 11.10 Mentor
  • 11.10.1 Mentor Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Mentor Botulinum Neurotoxins Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Mentor Botulinum Neurotoxins Products Offered
  • 11.10.5 Mentor Recent Development
• 11.11 CROMA
• 11.12 Alphaeon
• 11.13 OBI Pharma
• 11.14 Revance Therapeutics
• 11.15 Daewoong Pharmaceutical
• 11.16 Medy-Tox
• 11.17 EpiVax
• 11.18 Anterios
• 11.19 Escape Therapeutics
• 11.20 Lipella
• 11.21 Malvern Cosmeceutics
• 11.22 PharmaVital
• 11.23 Merz Pharma
• 11.24 Transdermal
• 11.25 Valeant Pharmaceuticals
• 11.26 CNBG

12 Future Forecast

• 12.1 Botulinum Neurotoxins Market Forecast by Regions
  • 12.1.1 Global Botulinum Neurotoxins Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Botulinum Neurotoxins Revenue Forecast by Regions 2019-2025
• 12.2 Botulinum Neurotoxins Market Forecast by Product
  • 12.2.1 Global Botulinum Neurotoxins Sales Forecast by Product 2019-2025
  • 12.2.2 Global Botulinum Neurotoxins Revenue Forecast by Product 2019-2025
• 12.3 Botulinum Neurotoxins Market Forecast by End User
• 12.4 North America Botulinum Neurotoxins Forecast
• 12.5 Europe Botulinum Neurotoxins Forecast
• 12.6 Asia Pacific Botulinum Neurotoxins Forecast
• 12.7 Central & South America Botulinum Neurotoxins Forecast
• 12.8 Middle East and Africa Botulinum Neurotoxins Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Botulinum Neurotoxins Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details